These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 34886782)

  • 1. Incidence of Restenosis Following Rapamycin or Paclitaxeleluting Stent in Coronary Stent Implantation.
    Shakarami A
    Cardiovasc Hematol Disord Drug Targets; 2021; 21(3):196-201. PubMed ID: 34886782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proximal coronary artery intervention: stent thrombosis, restenosis and death.
    Calais F; Lagerqvist B; Leppert J; James SK; Fröbert O
    Int J Cardiol; 2013 Dec; 170(2):227-32. PubMed ID: 24211065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic assessment of the left main-left circumflex bending angle: Implications for ostial left circumflex artery in-stent restenosis after successful two-stent PCI.
    Wang Z; Yang J; Li C; Huang J; Fezzi S; Chen E; Cai W; Stankovic G; Wijns W; Chen L; Tu S
    Int J Cardiol; 2023 May; 378():11-19. PubMed ID: 36796487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of coronary anatomy and stenting technique on long-term outcome after drug-eluting stent implantation for unprotected left main coronary artery disease.
    Tiroch K; Mehilli J; Byrne RA; Schulz S; Massberg S; Laugwitz KL; Vorpahl M; Seyfarth M; Kastrati A;
    JACC Cardiovasc Interv; 2014 Jan; 7(1):29-36. PubMed ID: 24332416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Occurrence and predictive factors of restenosis in coronary heart disease patients underwent sirolimus-eluting stent implantation.
    Zhao J; Wang X; Wang H; Zhao Y; Fu X
    Ir J Med Sci; 2020 Aug; 189(3):907-915. PubMed ID: 31989420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Outcome of Percutaneous Coronary Intervention for Significant Atherosclerotic Lesions in Segment Proximal to Myocardial Bridge at Left Anterior Descending Coronary Artery.
    Hao Z; Xinwei J; Ahmed Z; Huanjun P; Zhanqi W; Yanfei W; Chunhong C; Chan Z; Liqiang F
    Int Heart J; 2018 May; 59(3):467-473. PubMed ID: 29681571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of clinical outcomes using stents versus no stents after percutaneous coronary intervention for proximal left anterior descending versus proximal right and left circumflex coronary arteries.
    Ashby DT; Dangas G; Mehran R; Lansky AJ; Narasimaiah R; Iakovou I; Polena S; Satler LF; Pichard AD; Kent KM; Stone GW; Leon MB
    Am J Cardiol; 2002 May; 89(10):1162-6. PubMed ID: 12008168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictor of in-stent restenosis in patients with drug-eluting stent (PRIDE)- a retrospective cohort study.
    Gupta PK; Balachander J
    Clin Investig Arterioscler; 2021; 33(4):184-194. PubMed ID: 33622608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between left coronary artery bifurcation angle and restenosis after stenting of the proximal left anterior descending artery.
    Konishi T; Yamamoto T; Funayama N; Nishihara H; Hotta D
    Coron Artery Dis; 2016 Sep; 27(6):449-59. PubMed ID: 27214275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In-stent restenosis is inhibited in a bare metal stent implanted distal to a sirolimus-eluting stent to treat a long de novo coronary lesion with small distal vessel diameter.
    Obata JE; Nakamura T; Kitta Y; Saito Y; Sano K; Fujioka D; Kawabata K; Kugiyama K
    Catheter Cardiovasc Interv; 2013 Nov; 82(6):E777-87. PubMed ID: 23378231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiographic and clinical outcome of percutaneous coronary intervention for in-stent restenosis of bifurcated lesions.
    Coroleu SF; De Vita M; Burzotta F; Trani C; Porto I; Niccoli G; Leone AM; Tommasino A; Talarico GP; Schiavoni G; Crea F
    EuroIntervention; 2012 Oct; 8(6):701-7. PubMed ID: 23086788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive analysis of predictive factors for rapid angiographic stenotic progression and restenosis risk in coronary artery disease patients underwent percutaneous coronary intervention with drug-eluting stents implantation.
    Wu Y; Fu X
    J Clin Lab Anal; 2019 Feb; 33(2):e22666. PubMed ID: 30221497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for in-stent restenosis after coronary stent implantation in patients with coronary artery disease: A retrospective observational study.
    Zhang J; Zhang Q; Zhao K; Bian YJ; Liu Y; Xue YT
    Medicine (Baltimore); 2022 Nov; 101(47):e31707. PubMed ID: 36451388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors of in-stent restenosis among coronary artery disease patients with syphilis undergoing percutaneous coronary intervention: a retrospective study.
    Zhang L; Wang Y; Zhang Z; Liang H; Wu L; Ni L; Gao G; Yang D; Zhao H; Xiao J
    BMC Cardiovasc Disord; 2021 Sep; 21(1):438. PubMed ID: 34525967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for instent restenosis of sirolimus-coated stents in coronary intervention for patients with unstable angina.
    Liu D; Xue Z; Qi J; Yin L; Duan B; Wu L; Yang K; Gao B; Cao Q; Mi J
    Sci Rep; 2024 Jan; 14(1):2537. PubMed ID: 38291094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repeated sirolimus-eluting stent implantation to treat sirolimus-eluting stent and bare-metal stent restenosis.
    Nishihira K; Shibata Y; Ishikawa T; Nomura K; Nakama T; Mine D; Inoue Y; Ashikaga K; Kuriyama N; Matsuyama A; Imamura T; Asada Y; Kitamura K
    Circ J; 2010 Nov; 74(11):2329-33. PubMed ID: 20890050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The characteristics and risk factors of in-stent restenosis in patients with percutaneous coronary intervention: what can we do.
    Wang P; Qiao H; Wang R; Hou R; Guo J
    BMC Cardiovasc Disord; 2020 Dec; 20(1):510. PubMed ID: 33276720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three- and 6-month optical coherence tomographic surveillance following percutaneous coronary intervention with the Angiolite® drug-eluting stent: The ANCHOR study.
    Puri R; Otaegui I; Sabaté M; Serra-Peñaranda A; Puigfel M; Perez de Prado A; Nombela-Franco L; de la Torre Hernandez JM; Ortas Nadal R; Iniguez-Romo A; Jiménez G; Fernandez-Vazquez F; Cuellas-Ramon C; Gonzalo N; Alfonso Jiménez Diaz V; Duocastella L; Molina M; Amoros M; Perez I; Barria Perez A; Pelletier Beaumont E; Nicholls SJ; Garcia Del Blanco B; Rodés-Cabau J
    Catheter Cardiovasc Interv; 2018 Feb; 91(3):435-443. PubMed ID: 28707379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The number of stents was an independent risk of stent restenosis in patients undergoing percutaneous coronary intervention.
    Tang L; Cui QW; Liu DP; Fu YY
    Medicine (Baltimore); 2019 Dec; 98(50):e18312. PubMed ID: 31852115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-Fasting Hypertriglyceridemia as an Independent Risk Factor for Coronary In-Stent Restenosis after Primary Bare Metal Stent Implantation in Patients with Coronary Artery Disease.
    Yoshimura M; Umemoto S; Kawano R; Hiromoto M; Yamada M; Fujimura T; Tanaka M; Nao T; Miura T; Yano M
    Int Heart J; 2021; 62(5):970-979. PubMed ID: 34588411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.